The SUSTAIN cardiovascular outcome trial programme demonstrating significant reduction in major adverse cardiovascular events in type 2 diabetes patients, and the SELECT trial demonstrating cardiovascular event reduction in obese patients without diabetes, have further established Semaglutide as a cardioprotective agent with GLP-1R-mediated cardiovascular biology extending beyond glycaemic and weight management
Our guide to the cost of GLP-1 medications explains typical price ranges
Methylcobalamin injections deliver B12 directly into the bloodstream through an intramuscular injection
Seek prompt medical attention at our practice if you have a wound exhibiting signs of infection, such as redness, warmth, swelling, increased pain, or discharge
By combining GLP-1 medications with holistic lifestyle changes, we aim to empower our patients on their path to sustainable weight loss and improved overall health
Our team generally finds that a 5 mg/mL or 10 mg/mL concentration covers most research needs effectively